Skip to main content
Clinical Trials/NCT00379171
NCT00379171
Completed
Not Applicable

The Importance of Complementary Feeding on Growth, Nutritional Status and Markers for Disease. An Intervention Study With Milk Types and LC-PUFA Supplements in 9- to 12-Month-Old Infants

University of Copenhagen0 sites100 target enrollmentMay 2003

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
University of Copenhagen
Enrollment
100
Primary Endpoint
Growth
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

The objective of this intervention study is to examine the effect of whole cow's milk versus infant formula as primary milk sources with or without supplements of n-3 LCPUFA for growth, nutritional status, development, risk factors for later diseases and the impact on the intestinal microbiota and inflammation in 9 - 12 months old infants.

Registry
clinicaltrials.gov
Start Date
May 2003
End Date
March 2004
Last Updated
17 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Singleton infants
  • Born \>= 37 wk of gestation
  • Birth weight \> 2500g
  • \>= 5th percentile for gestational age
  • A 5-min Apgar score \>= 7
  • Daily consumption of cow's milk or formula

Exclusion Criteria

  • No major complications at birth or in fetal life
  • No chronic diseases

Outcomes

Primary Outcomes

Growth

Body composition (weight, length, knee-heel-length, waist, head, and arm circumference, skin fold measurements).

IGF-I

IGFBP-3

Insulin - glucose metabolism (HOMA index).

Urea Nitrogen

Albumin

C-peptide

Amino Acids

Erythrocyte fatty acid composition

Blood pressure

Lipid Profile

Heart Rate Variability (HRV)

In vitro cytokine production from stimulated full blood (IL-10, IFN-gamma, TNF-alpha)

Plasma IgE, IL-2R, and CRP

Secondary Outcomes

  • Plasma concentrations of cholesterol and triglycerides
  • Allergy status
  • Cognitive test ("The infant means-end problem solving test")
  • Iron status (hemoglobin, ferritin and transferrin receptors)
  • Feces samples: Calprotectin, IgA and composition of the intestinal microbiota

Similar Trials